T. Rowe Price Associates’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-44,832
| Closed | -$82K | – | 2946 |
|
|
2022
Q3 | $82K | Sell |
44,832
-74,619
| -62% | -$136K | ﹤0.01% | 2765 |
|
|
2022
Q2 | $376K | Hold |
119,451
| – | – | ﹤0.01% | 2334 |
|
|
2022
Q1 | $738K | Buy |
+119,451
| New | +$738K | ﹤0.01% | 2158 |
|
|
2021
Q4 | – | Sell |
-24,303
| Closed | -$194K | – | 2996 |
|
|
2021
Q3 | $194K | Hold |
24,303
| – | – | ﹤0.01% | 2729 |
|
|
2021
Q2 | $694K | Buy |
+24,303
| New | +$694K | ﹤0.01% | 2217 |
|